Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be administered in pill form for weight loss. “With today’s approval of the Wegovy pill, patients will have a convenient, once-daily pill that can help them lose as much weight as the…
The U.S. Food and Drug Administration has approved Novartis‘ gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday. The therapy, branded as Itvisma, was approved for the treatment of spinal muscular atrophy patients of age two years and older who have a confirmed mutation in the survival motor neuron 1…
AbbVie to Launch Ovarian Cancer Drug ELAHERE in UK at US Price Levels We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Zydus Lifesciences on Thursday said its subsidiary has joined hands with the Netherlands-based Synthon BV to introduce a generic drug for the treatment of multiple sclerosis in the US market.Zydus Lifesciences Global FZE has entered into an exclusive licensing and supply agreement with Synthon BV for Ozanimod capsules (a generic version of ZEPOSIA) for the…